Merck buying Twin Cities medtech firm Bio-Techne for $11.3B
- Posted on June 25, 2026
- By Star Tribune
- 0 Views
- 1 min read
Merck buying Twin Cities medtech firm Bio-Techne for $11.3B
The 50-year-old Bio-Techne was under activist pressure to sell, according to reports.